Navigation Links
Noted Vertebroplasty Expert Cites Concerns About Recently Published Study
Date:8/11/2009

ntended group size would have yielded a different outcome."

Additionally, selection bias could have also played a large part in the study's results. "Only 131 out of 431 (30.4 percent) eligible patients elected to participate, increasing the potential for selection bias," noted Dr. Syed.

A third issue was the crossover rate for patients who received the control or "placebo" procedure. Patients in the trial were able to "cross over" and get the other treatment after one month.

"Even though they had no confirmation of which treatment they received, nearly four times as many patients or 43 percent who had the control treatment crossed over to have vertebroplasty performed, compared to 12 percent of vertebroplasty patients who switched," said Dr. Syed.

The final issue to consider is that the control procedure included injecting 0.25 percent of bupivicaine into the periosteum of the pedicles. "The problem," explained Dr. Syed, "is that this resembles a medial branch block for the treatment of facet-related pain. The duration of relief following medial branch block is variable, but may last for several weeks."

He added that many patients with compression fractures have concurrent facet-related pain due to stress on the facet joint as a result of the fracture.

"I applaud Dr. Kallmes for his work. His study is very interesting, but I don't think it's conclusive. Additional research is needed to truly assess the efficacy of vertebroplasty," said Dr. Syed.

Dr. Syed is on staff at Good Samaritan Hospital and Dayton Heart Hospital in Dayton. He is also a founding partner of Dayton Interventional Radiology. In addition, Dr. Syed has participated in clinical trials and published several papers on vertebroplasty.


'/>"/>
SOURCE Dr. Mubin I. Syed
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Signs of Depression Noted in Second Graders
2. UPDATE: Swine Flu Spread Will Trigger Difficult Legal Questions for Employers Says Noted Pillsbury Attorney
3. Swine Flu Plans Triggering Difficult Legal Questions, Says Noted Pillsbury Attorney
4. Kouros Azar, M.D. (doctorazar.com), Noted Plastic and Reconstructive Surgeon, Offers Top 10 Tips to Patients to Help Celebrate National Patient Safety Awareness Week
5. Noted State Government Medical Director Dr. Stephen Saunders To Join APS Healthcare
6. Three Noted Women of Valor to be Honored at Los Angeles Jewish Home Gala Dinner
7. 4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists
8. Noted Litigator Peter Diedrich Joins Musick Peeler & Garrett LLP
9. 39 Noted Performing Artists Urge Congress to Fix Flaws in Presidents Global AIDS Plan
10. Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson
11. Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading: Studies Actually Show it is Effective at Reducing Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Research Triangle Park, NC (PRWEB) July 24, 2014 ... the elderly, ethnic minorities, and low-income households are ... private and public food safety net in the ... RTI International. , Under Section 743 of the ... the U.S. Department of Agriculture's Food and Nutrition ...
(Date:7/24/2014)... July 24, 2014 The federal ... ) in the U.S. District Court, District ... for plaintiff medical information covered by the federal ... the July 16th Order, U.S. District Judge Douglas ... Fresenius Medical Care the right to receive HIPAA- ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, 2014 (HealthDay ... dead wrong, according to a small study that asked boys what ... boys between the ages of 14 and 16, researchers found that ... closeness and trust. Very few boasted about sexual conquests or saw ... girl. "In our culture, we have lots of assumptions about ...
(Date:7/24/2014)... By Kathleen Doheny ... -- Parents of obese children often don,t view their kids ... or inactivity, according to a new study. The children ... an obesity clinic at the Hasbro Children,s Hospital in Providence, ... or very good," said study researcher Dr. Kyung Rhee, now ...
(Date:7/24/2014)... School of Medicine researchers may have found a way ... discovered that pre-treatment of neurons with the anti-aging protein ... the toxic amyloid protein and glutamate. These findings currently ... , Alzheimer,s disease is the most frequent age-related ... people age 65 and older and more than 40 ...
Breaking Medicine News(10 mins):Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2
... , , STEWARTVILLE, Minn., July 30 Rochester ... third quarter ended June 30, 2009. , , The Company ... third quarter of last year. The Company also reported net loss of ... of $312,000 or $.02 per diluted share for the same period of last ...
... INDIANAPOLIS, July 30 WellPoint, Inc. (NYSE: ... for the administration of the H1N1 (swine flu) vaccine when ... administration will be covered for members whose benefit plans provide ... also continue coverage of seasonal flu vaccine administration for those ...
... , , , , ... today reported revenue for the second quarter of 2009 of $41.0 million. ... to revenue of $42.1 million and a net loss of $7.7 million, ... , Excluding amortization of purchased intangible assets, stock compensation and ...
... shows they,re at increased risk of psychological distress years ... survivors are more likely than their healthy peers to ... even a decade after treatment ends, new research shows. ... of diagnosis, unmarried, had less than a high school ...
... , Perkins challenges Planned Parenthood President to Debate ... Research Council Action President Tony Perkins today urged the House Energy ... of health care providers and ensure that Americans, tax dollars are ... Perkins also responded to attacks by Planned Parenthood and the ...
... , WASHINGTON, July 30 An estimated ... if Congress passes a House health reform bill, according to ... 2009 released this week by The Heritage ... The Lewin Group , a highly respected health ...
Cached Medicine News:Health News:Rochester Medical Reports Third Quarter Results 2Health News:Rochester Medical Reports Third Quarter Results 3Health News:Rochester Medical Reports Third Quarter Results 4Health News:Rochester Medical Reports Third Quarter Results 5Health News:Rochester Medical Reports Third Quarter Results 6Health News:Rochester Medical Reports Third Quarter Results 7Health News:Rochester Medical Reports Third Quarter Results 8Health News:Rochester Medical Reports Third Quarter Results 9Health News:Rochester Medical Reports Third Quarter Results 10Health News:Rochester Medical Reports Third Quarter Results 11Health News:WellPoint Announces Decision to Cover H1N1 Vaccine Administration 2Health News:Cepheid Reports 2009 Second Quarter Results 2Health News:Cepheid Reports 2009 Second Quarter Results 3Health News:Cepheid Reports 2009 Second Quarter Results 4Health News:Cepheid Reports 2009 Second Quarter Results 5Health News:Cepheid Reports 2009 Second Quarter Results 6Health News:Cepheid Reports 2009 Second Quarter Results 7Health News:Cepheid Reports 2009 Second Quarter Results 8Health News:Cepheid Reports 2009 Second Quarter Results 9Health News:Cepheid Reports 2009 Second Quarter Results 10Health News:Cepheid Reports 2009 Second Quarter Results 11Health News:Cepheid Reports 2009 Second Quarter Results 12Health News:Cepheid Reports 2009 Second Quarter Results 13Health News:Cepheid Reports 2009 Second Quarter Results 14Health News:Cepheid Reports 2009 Second Quarter Results 15Health News:Cepheid Reports 2009 Second Quarter Results 16Health News:Cepheid Reports 2009 Second Quarter Results 17Health News:Cepheid Reports 2009 Second Quarter Results 18Health News:Cancer Survivors Face Tough Road Long After Treatment Ends 2Health News:Cancer Survivors Face Tough Road Long After Treatment Ends 3Health News:FRC: The Truth Hurts Planned Parenthood and NARAL 2Health News:Millions of Virginians Could Lose Private Insurance, Study Shows 2
(Date:7/24/2014)... July 24, 2014  Kinex Pharmaceuticals announced the receipt ... Company,s KX2-391 Ointment for the commencement of a Phase ... Company,s third IND to be allowed by the US ... is a synthetic, orally active and highly selective inhibitor ... promotes the induction of p53, G2/M arrest of proliferating ...
(Date:7/24/2014)... , July 24, 2014 Research ... "Machine Health Monitoring Market by Product, Component, Application and ... report to their offering. ... market is expected to witness a moderate growth as ... have almost reached the saturation levels. The ...
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- "North America ... key market data on the North America Orthopedic Braces ... of US dollars, and volume (in units) and average ... , Knee Braces and Supports , Ankle ... , Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... , NEW ... new market research report is available in its ... Global Market Review , http://www.reportlinker.com/p0164324/Holter-Monitoring-Systems---A-Global-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... is extremely beneficial for cardiac patients. High-risk patients ...
... , BIRMINGHAM, ... University of Alabama at Birmingham (UAB), and Southern Research Institute ... their collective innovation and enabling technologies in the areas of ... U.S.-India arbitraged and leveraged partnership that will accelerate the development ...
Cached Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Reportlinker Adds Holter Monitoring Systems - A Global Market Review 6Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
... The DRS 2000, a uniquely intelligent system, ... its space saving, 2-level design. Up to 27 ... to give you the flexibility to tailor your ... lab. Two start stations allow for continuous loading; ...
... latest from the leader in automatic slide ... modern approach to slide staining, ending messy ... blood smears, bone marrow and other body ... Aerospray stainer becomes a superb cytocentrifuge with ...
Cholesterol FS. For determination of cholesterol in serum or plasma. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P Trulab L....
Medicine Products: